Volume 94, supplement 4, supplément FMC n°7, juillet 2007

Éditorial

Cancer de la prostate : les acquis récents et le futur presque immédiat (p.3-4)
Alain Ravaud, Jacques-Olivier Bay

Synthèse

T1-T2 prostate cancer: treatment by radiation therapy (p.5-14)
Jean-Léon Lagrange, Stéphane Guerif

Adjuvant medical treatment or radiotherapy following radical prostatectomy or curative radiotherapy (p.15-20)
Laurent Guy

Prostate cancer and chemotherapy (p.21-8)
Gwenaelle Gravis, Naji Salem, Franck Bladou, Patrice Viens

Interleukin-6 implication in prostate cancer (p.29-34)
Aurélie Cabrespine, Jacques-Olivier Bay, Pierre Verrelle, Laurent Morel

Prognostic factors of localised, locally advanced or metastatic prostate cancer (p.35-43)
Florence Joly, Michel Henry-Amar

Rare malignant tumours of the prostate (p.44-9)
Catherine Mazerolles, Christine Chevreau

Locally advanced prostate cancer : definition, prognosis and treatment (p.50-61)
Anne Plantade, Christophe Massard, Renaud de Crevoisier, Karim Fizazi

New targeted therapies in hormone-refractory prostate cancer (p.62-8)
Stéphane Oudard, Eugeniu Banu, Florian Scotte, Philippe Beuzeboc, Charlotte Guyader, Jacques Medioni

State of the art about new therapeutic vaccines in prostate cancer : dendritic cells, engineered tumor cells and recombinant virus (p.69-76)
Jean-Christophe Eymard, Alban Gervais, Rosana Jarcau, Jacky Bernard

Molecular aspects of prostate cancer: recent data from the literature (p.77-88)
Philippe Camparo, Annick Vieillefond

Metastatic prostate cancer treatment in the elderly (p.89-96)
Claire Falandry, Marc Bonnefoy, Benoît You, Gilles Freyer